In-depth research
for regulated AI.

With MedStride

This white paper examines the regulatory landscape for AI-enabled medical devices under EU MDR, and demonstrates how Xybern's authorisation layer provides a technically and legally defensible authorisation mechanism for Article 22 compliance, with a case study on the MedStride deployment.

With TEQ-IT

This white paper examines how AI agents operating inside SAP introduce new authorisation and compliance challenges, and demonstrates how Xybern's authorisation layer provides a technically defensible control mechanism for every agent action, with a case study on the TEQ-IT deployment across finance and procurement workflows.